GeoVax ^Investors

GeoVax is an innovative biotechnology company based in Smyrna, Georgia, United States, founded in 1988 The company specializes in the development of vaccines and immunotherapies for infectious diseases and cancer GeoVax has garnered significant investment from various angel groups, reflecting strong confidence in its research and development capabilities The firm is dedicated to advancing its proprietary platform technologies to address critical health challenges With a focus on both domestic and international markets, GeoVax aims to make a substantial impact in the field of vaccine development